- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Inotersen is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- N07 Other nervous system medicines
- US FDA first approval
- 5 October 2018
- EU status
- Authorised
- Orphan designation
- Yes
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- RxCUI 2099289Q27236822
All presentations
No presentations of Inotersen are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Inotersen available for export from India?
No presentation of Inotersen is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Inotersen approved by the US FDA?
Yes. The US FDA first approved Inotersen on 5 October 2018, according to Drugs@FDA.
Is Inotersen authorised in the European Union?
Yes. Inotersen has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Inotersen need cold chain shipping?
No listed presentation of Inotersen is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Inotersen in?
Inotersen is classified under ATC code N07 (Other nervous system medicines).
References
- Tegsedi: European public assessment report (EPAR). European Medicines Agency. Retrieved 4 June 2026
Request Inotersen for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.